Publication | Open Access
FP13.02 Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189
39
Citations
0
References
2021
Year
OncologyMetronomic TherapyClinical TrialsMetastatic Nsclc4-Year Follow-upCancer TreatmentMedicineRadiation OncologyHealth Sciences
No additional data available for this publication yet. Check back later!